Oncology ASCO 2025: Breast cancer breakthroughs drive HCPs’ online co... Every year at ASCO, we see new data. New combinations. New standards of care.
Sales & Marketing ASCO unpacked: Signals for optimising healthcare comms Earlier this month, more than 45,000 oncology stakeholders convened at the American Society of Clinical Oncology (ASCO) congress in Chicago to share, learn, and debate the latest cutting-ed
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
